Wilson Sonsini Goodrich & Rosati advised Tybourne Capital Management on the deal.Zentera Therapeutics, a clinical-stage biopharmaceutical company, completed a $75 million Series B financing. Founding investors OrbiMed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
